Enterprise Partnerships Biofourmis is trusted by leading health systems, payers, biopharma companies and patients, signaling strong interest from large healthcare buyers and potential for expanded partnerships with hospitals, integrated delivery networks, and pharma sponsors.

Acquisition Activity Recent and notable M&A activity including the acquisition of PhysioWave and the merger with CopilotIQ indicate Biofourmis is expanding its capabilities in digital therapeutics and AI-driven remote care, creating sales opportunities for integrated platform solutions and cross-sell.

In Home Care Growth Launches of AI-driven in-home care platforms and home-based remote monitoring align with demand for hospital-at-home and RPM programs, suggesting upsell opportunities with health systems and payers pursuing home-based care strategies.

EHR & Data Integration Successful integrations with Epic EHR and real-time data flows across biomarkers position Biofourmis as a data-enabled partner; opportunities exist to expand connectors with additional EHRs, interoperability vendors, and clinical trial platforms.

Global Expansion & Capabilities With headquarters in Boston and offices in Singapore and India, plus a track record of global deployments, Biofourmis offers scalable, multinational implementations suitable for large enterprise clients, pharma collaborations, and diverse regulatory environments.